Niclosamide Oral Tablet

DRUG3 trials

Sponsors

Entero Therapeutics, University of Baghdad

Conditions

COVIDCovid-19Covid19SARS Pneumonia

Phase 2

Niclosamide In Moderate COVID-19

WithdrawnNCT04436458

Entero TherapeuticsCOVID

Start: 2022-01-20End: 2022-01-20Updated: 2022-02-21

Niclosamide in COVID-19

WithdrawnNCT04542434

Entero TherapeuticsCovid19

Start: 2022-01-20End: 2022-01-20Updated: 2022-02-21

Effectiveness of Niclosamide as Add-on Therapy to the Standard of Care Measures in COVID-19 Management

University of BaghdadCovid-19, SARS Pneumonia

Start: 2021-01-03End: 2021-12-03Target: 150Updated: 2021-06-22